SOAT1 and intervertebral disk degenerative disorder: Targeting the JAK-STAT pathway could reduce inflammation and apoptosis in IDD, potentially offering a strategy to halt or reverse disease progression. Combination therapies targeting both JAK and STAT proteins may provide enhanced efficacy.